デフォルト表紙
市場調査レポート
商品コード
1411557

細胞増殖キット市場:タイプ別、エンドユーザー別-2024-2030年の世界予測

Cell Proliferation Kits Market by Type (Colorimetry, Fluorescence), End-user (Academic & Research Institutes, Pharma & Biotech Companies) - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 188 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
細胞増殖キット市場:タイプ別、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月16日
発行: 360iResearch
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞増殖キット市場規模は2023年に23億8,000万米ドルと推計され、2024年には25億5,000万米ドルに達し、CAGR 7.40%で2030年には39億2,000万米ドルに達すると予測されます。

細胞増殖キットの世界市場

主な市場の統計
基準年[2023] 23億8,000万米ドル
予測年[2024] 25億5,000万米ドル
予測年 [2030] 39億2,000万米ドル
CAGR(%) 7.4%
細胞増殖キット Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは細胞増殖キット市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、細胞増殖キット市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1-市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1-細胞増殖キット市場の市場規模および予測は?

2-細胞増殖キット市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3-細胞増殖キット市場における技術動向と規制の枠組みは?

4-細胞増殖キット市場における主要ベンダーの市場シェアは?

5-細胞増殖キット市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 製薬会社やバイオテクノロジー企業による創薬のための研究開発の増加
      • 個別化医療への移行が進む
    • 抑制要因
      • 細胞増殖キットの開発コストが高い
    • 機会
      • 細胞増殖キットの開発がますます進歩
      • 幹細胞分野の調査が急増
    • 課題
      • 細胞増殖キットの互換性の問題
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 細胞増殖キット市場:タイプ別

  • 測色
  • 蛍光

第7章 細胞増殖キット市場:エンドユーザー別

  • 学術調査機関
  • 製薬会社およびバイオテクノロジー企業

第8章 南北アメリカの細胞増殖キット市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の細胞増殖キット市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの細胞増殖キット市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • AAT Bioquest, Inc.
    • Abcam PLC
    • Agilent Technologies, Inc.
    • Beckman Coulter, Inc. by Danaher Corporation
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Biotium, Inc.
    • Cell Signaling Technology, Inc.
    • Corning Incorporated
    • DiscoverX Corporation by Eurofins Scientific(Ireland)Limited
    • Elabscience
    • Enzo Life Sciences, Inc.
    • Lonza Group Ltd.
    • Merck KGaA
    • PerkinElmer Inc.
    • Promega Corporation
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. CELL PROLIFERATION KITS MARKET RESEARCH PROCESS
  • FIGURE 2. CELL PROLIFERATION KITS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. CELL PROLIFERATION KITS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CELL PROLIFERATION KITS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. CELL PROLIFERATION KITS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CELL PROLIFERATION KITS MARKET DYNAMICS
  • FIGURE 7. CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 10. CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS CELL PROLIFERATION KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS CELL PROLIFERATION KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES CELL PROLIFERATION KITS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES CELL PROLIFERATION KITS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC CELL PROLIFERATION KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC CELL PROLIFERATION KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CELL PROLIFERATION KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL PROLIFERATION KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. CELL PROLIFERATION KITS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. CELL PROLIFERATION KITS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. CELL PROLIFERATION KITS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. CELL PROLIFERATION KITS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL PROLIFERATION KITS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. CELL PROLIFERATION KITS MARKET SIZE, BY COLORIMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CELL PROLIFERATION KITS MARKET SIZE, BY FLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 9. CELL PROLIFERATION KITS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CELL PROLIFERATION KITS MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AMERICAS CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS CELL PROLIFERATION KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 14. ARGENTINA CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. BRAZIL CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. CANADA CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. MEXICO CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. UNITED STATES CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES CELL PROLIFERATION KITS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 25. ASIA-PACIFIC CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC CELL PROLIFERATION KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. AUSTRALIA CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CHINA CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. INDIA CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. INDONESIA CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. JAPAN CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MALAYSIA CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. PHILIPPINES CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. SINGAPORE CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. SOUTH KOREA CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. TAIWAN CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. THAILAND CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. VIETNAM CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA CELL PROLIFERATION KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. DENMARK CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EGYPT CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. FINLAND CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. FRANCE CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. GERMANY CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ISRAEL CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ITALY CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. NETHERLANDS CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. NIGERIA CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NORWAY CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. POLAND CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. QATAR CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. RUSSIA CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SAUDI ARABIA CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH AFRICA CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SPAIN CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SWEDEN CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SWITZERLAND CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TURKEY CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED ARAB EMIRATES CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED KINGDOM CELL PROLIFERATION KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM CELL PROLIFERATION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. CELL PROLIFERATION KITS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 98. CELL PROLIFERATION KITS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 99. CELL PROLIFERATION KITS MARKET LICENSE & PRICING
目次
Product Code: MRR-007C484E5E6D

[188 Pages Report] The Cell Proliferation Kits Market size was estimated at USD 2.38 billion in 2023 and expected to reach USD 2.55 billion in 2024, at a CAGR 7.40% to reach USD 3.92 billion by 2030.

Global Cell Proliferation Kits Market

KEY MARKET STATISTICS
Base Year [2023] USD 2.38 billion
Estimated Year [2024] USD 2.55 billion
Forecast Year [2030] USD 3.92 billion
CAGR (%) 7.4%
Cell Proliferation Kits Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Proliferation Kits Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Proliferation Kits Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Proliferation Kits Market, highlighting leading vendors and their innovative profiles. These include AAT Bioquest, Inc., Abcam PLC, Agilent Technologies, Inc., Beckman Coulter, Inc. by Danaher Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biotium, Inc., Cell Signaling Technology, Inc., Corning Incorporated, DiscoverX Corporation by Eurofins Scientific (Ireland) Limited, Elabscience, Enzo Life Sciences, Inc., Lonza Group Ltd., Merck KGaA, PerkinElmer Inc., Promega Corporation, Sartorius AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Proliferation Kits Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Colorimetry
    • Fluorescence
  • End-user
    • Academic & Research Institutes
    • Pharma & Biotech Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Proliferation Kits Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Proliferation Kits Market?

3. What are the technology trends and regulatory frameworks in the Cell Proliferation Kits Market?

4. What is the market share of the leading vendors in the Cell Proliferation Kits Market?

5. Which modes and strategic moves are suitable for entering the Cell Proliferation Kits Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cell Proliferation Kits Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing research & development by pharmaceutical & biotech companies for drug discovery
      • 5.1.1.2. Growing shift toward personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development of cell proliferation kits
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing advancements in the development of cell proliferation kits
      • 5.1.3.2. Rapid increase in research in the field of stem cell
    • 5.1.4. Challenges
      • 5.1.4.1. Compatibility issues with cell proliferation kits
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Cell Proliferation Kits Market, by Type

  • 6.1. Introduction
  • 6.2. Colorimetry
  • 6.3. Fluorescence

7. Cell Proliferation Kits Market, by End-user

  • 7.1. Introduction
  • 7.2. Academic & Research Institutes
  • 7.3. Pharma & Biotech Companies

8. Americas Cell Proliferation Kits Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cell Proliferation Kits Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cell Proliferation Kits Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. AAT Bioquest, Inc.
    • 12.1.2. Abcam PLC
    • 12.1.3. Agilent Technologies, Inc.
    • 12.1.4. Beckman Coulter, Inc. by Danaher Corporation
    • 12.1.5. Becton, Dickinson and Company
    • 12.1.6. Bio-Rad Laboratories, Inc.
    • 12.1.7. Biotium, Inc.
    • 12.1.8. Cell Signaling Technology, Inc.
    • 12.1.9. Corning Incorporated
    • 12.1.10. DiscoverX Corporation by Eurofins Scientific (Ireland) Limited
    • 12.1.11. Elabscience
    • 12.1.12. Enzo Life Sciences, Inc.
    • 12.1.13. Lonza Group Ltd.
    • 12.1.14. Merck KGaA
    • 12.1.15. PerkinElmer Inc.
    • 12.1.16. Promega Corporation
    • 12.1.17. Sartorius AG
    • 12.1.18. Thermo Fisher Scientific Inc.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing